| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |